NuVasive® is a medical device company focused on developing minimally disruptive surgical products and procedurally integrated solutions for the spine. The Company is the third largest medical device company in the $8.2 billion global spine market. NuVasive’s principal product offering is based on its Maximum Access Surgery, or MAS® platform. The MAS platform combines several categories of solutions that collectively minimize soft tissue disruption during spine surgery with maximum visualization and safe, easy reproducibility for the surgeon: a proprietary software-driven nerve avoidance system and intra-operative monitoring support; MaXcess®, a unique split-blade retractor system; a wide variety of specialized implants; and several biologic products to aid in the spinal fusion process. MAS significantly reduces surgery time and returns patients to activities of daily living much faster than conventional approaches. Having redefined spine surgery with the MAS platform’s lateral approach, known as eXtreme Lateral Interbody Fusion, or XLIF®, NuVasive has built an entire spine franchise. With over 90 products today spanning lumbar, thoracic and cervical applications, the Company will continue to expand and evolve its offering predicated on its R&D focus and dedication to outstanding service levels supported by a culture of Absolute Responsiveness®.
San Diego, US
1,600 (est)

NuVasive Locations

San Diego, US
Memphis, US
Columbia, US
Fairborn, US
Aliso Viejo, US
Kew, AU
Bremen, DE
Guaynabo, PR
Singapore, SG
Elstree, GB
Chūō-ku, JP
Milano, IT
Amstelveen, NL

NuVasive Metrics

NuVasive Summary

Founding Date


Market capitalization

$2.91 B

Closing share price


NuVasive Market Value History

NuVasive Online Presence

NuVasive Company Life